A W Alberts - JoVE Visualize

Showing results (41-50 of 53) with videos related to

Pageof 6

Sort By:

The Journal of Clinical Investigation|September 1, 1984

Plasma mevalonate as a measure of cholesterol synthesis in manT S Parker, D J McNamara, C D Brown, et al.

The Journal of Antibiotics|May 1, 1981

Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreusG Albers-Schönberg, H Joshua, M B Lopez, et al.

Journal of Medicinal Chemistry|August 1, 1991

3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivativesM E Duggan, A W Alberts, R Bostedor, et al.

Journal of Medicinal Chemistry|October 16, 1992

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogsG D Hartman, W Halczenko, M E Duggan, et al.

Journal of Lipid Mediators|June 1, 1993

MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factorS B Hwang, M H Lam, D M Szalkowski, et al.

The American Journal of Pathology|September 1, 1988

Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseP H Berry, J S MacDonald, A W Alberts, et al.

Biochemical and Biophysical Research Communications|February 15, 1988

(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.

Journal of Medicinal Chemistry|September 18, 1992

Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.

Journal of Medicinal Chemistry|February 1, 1986

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesG E Stokker, A W Alberts, P S Anderson, et al.

Journal of Medicinal Chemistry|March 1, 1985

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivativesG E Stokker, W F Hoffman, A W Alberts, et al.

Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:

Pageof 6

The Journal of Clinical Investigation|September 1, 1984

Plasma mevalonate as a measure of cholesterol synthesis in manT S Parker, D J McNamara, C D Brown, et al.

The Journal of Antibiotics|May 1, 1981

Dihydromevinolin, a potent hypocholesterolemic metabolite produced by Aspergillus terreusG Albers-Schönberg, H Joshua, M B Lopez, et al.

Journal of Medicinal Chemistry|August 1, 1991

3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivativesM E Duggan, A W Alberts, R Bostedor, et al.

Journal of Medicinal Chemistry|October 16, 1992

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 9. The synthesis and biological evaluation of novel simvastatin analogsG D Hartman, W Halczenko, M E Duggan, et al.

Journal of Lipid Mediators|June 1, 1993

MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factorS B Hwang, M H Lam, D M Szalkowski, et al.

The American Journal of Pathology|September 1, 1988

Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductaseP H Berry, J S MacDonald, A W Alberts, et al.

Biochemical and Biophysical Research Communications|February 15, 1988

(+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonistM M Ponpipom, S B Hwang, T W Doebber, et al.

Journal of Medicinal Chemistry|September 18, 1992

Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate esterN N Girotra, T Biftu, M M Ponpipom, et al.

Journal of Medicinal Chemistry|February 1, 1986

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivativesG E Stokker, A W Alberts, P S Anderson, et al.

Journal of Medicinal Chemistry|March 1, 1985

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivativesG E Stokker, W F Hoffman, A W Alberts, et al.

Pageof 6